FDA NDC Directory · JSON-LD · Markdown

Neostigmine

NDC 43598-528 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerDr.Reddy's Laboratories Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA209135
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsNEOSTIGMINE METHYLSULFATE (.5 mg/mL)
Marketing started20180904
Package count2

External sources

Source: openFDA. Public-domain (CC0).